Exhibit 10.3 LICENSE AND SPONSORED RESEARCH AGREEMENT THIS Agreement made and entered into this fifteenth day of September, 1998 by and between DUKE UNIVERSITY, a North Carolina not-for-profit corporation, (hereinafter called the "LICENSOR"), having...License and Sponsored Research Agreement • February 10th, 2003 • Microislet Inc • Biological products, (no disgnostic substances) • North Carolina
ContractLicense and Sponsored Research Agreement • May 5th, 2020 • Delaware
EX-10.31 7 v52057a5exv10w31.htm EX-10.31 Exhibit 10.31 EXCLUSIVE LICENSE AND SPONSORED RESEARCH AGREEMENT between OMEROS CORPORATION and MEDICAL RESEARCH COUNCIL This license agreement (the “Agreement”) is made effective the 31st day of October 2005 (the “Effective Date”) between Omeros Corporation, a Washington corporation having a principal place of business at 1420 Fifth Avenue, Suite 2600, Seattle WA 98101 USA (“Omeros”) and Medical Research Council, a United Kingdom governmental institution having a place of business at 20 Park Crescent, London, United Kingdom, W1B 1AL (“MRC”). WHEREAS MRC owns rights to certain technology related to mannan-binding lectin associated serine protease-2 (“MASP-2”), which technology was developed in part by Anthony C. Willis (“Mr. Willis”) working in an MRC laboratory under the direction of Professor Kenneth B. M. Reid (“Dr. Reid”), both employees of MRC; WHEREAS Omeros holds an exclusive, worldwide license to rights owned by the University of Leicest
